Alejandra Zepeda-Echavarria

Alejandra Zepeda-Echavarria

Auto-generated profile, based on publicly available information

Alejandra Zepeda-Echavarria

Department of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2023 in JMIR Cardio
Verified
Journal Article
Open access
AZAlejandra Zepeda-Echavarria
Alejandra Zepeda-Echavarria
RLRutger R van de Leur
Rutger R van de Leur
MSMeike van Sleuwen
Meike van Sleuwen
RHRutger J Hassink
Rutger J Hassink
TWThierry X Wildbergh
Thierry X Wildbergh
RERené van Es
René van Es
Background: Electrocardiograms (ECGs) are used by physicians to record, monitor, and diagnose the electrical activity of the heart. Recent technological advances have allowed ECG devices to move out of the clinic and into the home environment. There is a great variety of mobile ECG devices with the capabilities to be used in home environments. Objective: This scoping review aimed to provide a comprehensive overview of the current landscape of mobile ECG devices, including the technology used, intended clinical use, and available clinical evidence. Methods: We conducted a scoping review to identify studies concerning mobile ECG devices in the electronic database PubMed. Secondarily, an internet search was performed to identify other ECG devices available in the market. We summarized the devices’ technical information and usability characteristics based on manufacturer data such as datasheets and user manuals. For each device, we searched for clinical evidence on the capabilities to record heart disorders by performing individual searches in PubMed and ClinicalTrials.gov, as well as the Food and Drug Administration (FDA) 510(k) Premarket Notification and De Novo databases. Results: From the PubMed database and internet search, we identified 58 ECG devices with available manufacturer information. Technical characteristics such as shape, number of electrodes, and signal processing influence the capabilities of the devices to record cardiac disorders. Of the 58 devices, only 26 (45%) had clinical evidence available regarding their ability to detect heart disorders such as rhythm disorders, more specifically atrial fibrillation. Conclusions: ECG devices available in the market are mainly intended to be used for the detection of arrhythmias. No devices are intended to be used for the detection of other cardiac disorders. Technical and design characteristics influence the intended use of the devices and use environments. For mobile ECG devices to be intended to detect other cardiac disorders, challenges regarding signal processing and sensor characteristics should be solved to increase their detection capabilities. Devices recently released include the use of other sensors on ECG devices to increase their detection capabilities.

17 January 2024 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
PDF file
AZAlejandra Zepeda-Echavarria
Alejandra Zepeda-Echavarria
RLRutger R van de Leur
Rutger R van de Leur
MVMelle Vessies
Melle Vessies
NVNynke M de Vries
Nynke M de Vries
MSMeike van Sleuwen
Meike van Sleuwen
RERené van Es
René van Es
Aims: Many portable electrocardiogram (ECG) devices have been developed to monitor patients at home, but the majority of these devices are single lead and only intended for rhythm disorders. We developed the miniECG, a smartphone-sized portable device with four dry electrodes capable of recording a high-quality multi-lead ECG by placing the device on the chest. The aim of our study was to investigate the ability of the miniECG to detect occlusive myocardial infarction (OMI) in patients with chest pain. Methods and results: Patients presenting with acute chest pain at the emergency department of the University Medical Center Utrecht or Meander Medical Center, between May 2021 and February 2022, were included in the study. The clinical 12-lead ECG and the miniECG before coronary intervention were recorded. The recordings were evaluated by cardiologists and compared the outcome of the coronary angiography, if performed. A total of 369 patients were measured with the miniECG, 46 of whom had OMI. The miniECG detected OMI with a sensitivity and specificity of 65 and 92%, compared with 83 and 90% for the 12-lead ECG. Sensitivity of the miniECG was similar for different culprit vessels. Conclusion: The miniECG can record a multi-lead ECG and rule-in ST-segment deviation in patients with occluded or near-occluded coronary arteries from different culprit vessels without many false alarms. Further research is required to add automated analysis to the recordings and to show feasibility to use the miniECG by patients at home.

2 November 2022 in JMIR Preprints
Verified
Preprint
Open access
AZAlejandra Zepeda-Echavarria
Alejandra Zepeda-Echavarria
RLRutger R van de Leur
Rutger R van de Leur
MSMeike van Sleuwen
Meike van Sleuwen
RHRutger J Hassink
Rutger J Hassink
TWThierry X Wildbergh
Thierry X Wildbergh
RERené van Es
René van Es
BACKGROUND Electrocardiograms (ECGs) are used by physicians to record, monitor, and diagnose the electrical activity of the heart. Recent technological advances have allowed ECG devices to move out of the clinic and into the home environment. There is a great variety of mobile ECG devices with the capabilities to be used in home environments. OBJECTIVE This scoping review aimed to provide a comprehensive overview of the current landscape of mobile ECG devices, including the technology used, intended clinical use, and available clinical evidence. METHODS We conducted a scoping review to identify studies concerning mobile ECG devices in the electronic database PubMed. Secondarily, an internet search was performed to identify other ECG devices available in the market. We summarized the devices’ technical information and usability characteristics based on manufacturer data such as datasheets and user manuals. For each device, we searched for clinical evidence on the capabilities to record heart disorders by performing individual searches in PubMed and ClinicalTrials.gov, as well as the Food and Drug Administration (FDA) 510(k) Premarket Notification and De Novo databases. RESULTS From the PubMed database and internet search, we identified 58 ECG devices with available manufacturer information. Technical characteristics such as shape, number of electrodes, and signal processing influence the capabilities of the devices to record cardiac disorders. Of the 58 devices, only 26 (45%) had clinical evidence available regarding their ability to detect heart disorders such as rhythm disorders, more specifically atrial fibrillation. CONCLUSIONS ECG devices available in the market are mainly intended to be used for the detection of arrhythmias. No devices are intended to be used for the detection of other cardiac disorders. Technical and design characteristics influence the intended use of the devices and use environments. For mobile ECG devices to be intended to detect other cardiac disorders, challenges regarding signal processing and sensor characteristics should be solved to increase their detection capabilities. Devices recently released include the use of other sensors on ECG devices to increase their detection capabilities.

24 September 2024 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
PDF file
AZAlejandra Zepeda-Echavarria
Alejandra Zepeda-Echavarria
RLRutger R van de Leur
Rutger R van de Leur
PDP. A. Doevendans
P. A. Doevendans
We would like to thank Ratcliffe et al., for their letter in response to our manuscript ‘Detection of acute coronary occlusion with a novel mobile electrocardiogram device: a pilot study’.1 In their letter, they discuss the importance of triaging patients with cardiac chest pain, the use of mobile devices, and the necessity of correctly assessing acute coronary syndrome patients. They also bring out important questions regarding our study, and we believe that addressing these concerns is crucial. In this letter, we take the opportunity to respond to their points.

5 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JBJohanneke E. Ten Broeke
Johanneke E. Ten Broeke
AZAlejandra Zepeda-Echavarria
Alejandra Zepeda-Echavarria
RLRutger R. van de Leur
Rutger R. van de Leur
MVMelle Vessies
Melle Vessies
MMManon G. van der Meer
Manon G. van der Meer
BEBram van Es
Bram van Es
Background The miniECG, a smartphone-sized, multi-lead device, offers a simple and fast alternative to the 12-lead ECG. We aimed to demonstrate the potential of the miniECG to record and detect amplitude and intraventricular conduction ECG abnormalities via interpretable models. Methods A miniECG was captured for patients undergoing a conventional 12-lead ECG in the University Medical Centre Utrecht. MiniECGs of patients with normal ECGs (controls), amplitude abnormalities (low QRS voltage (Microvoltage) and left ventricular hypertrophy (LVH)), conduction abnormalities (left or right bundle branch blocks (LBBB, RBBB), left anterior fascicular block (LAFB), bifascicular block (BfB)) were selected. Standard ECG-features were used as input for decision trees (DTs) for binary (normal vs abnormal) or multiclass classification, employing 10-fold stratified cross-validation. Results 1717 patients were included. For binary classification of conduction abnormalities, the decision tree showed an AUROC of 0.97±0.01 (NPV 0.95±0.03, sensitivity 0.95±0.02). For multiclass classification, AUROCs were 0.95±0.02 (BfB), 0.85±0.03 (LAFB), 0.87±0.05 (LBBB), 0.94±0.04 (RBBB) and 0.93±0.03 (controls). For binary classification of amplitude abnormalities, the AUROC was 0.76±0.04 (NPV 0.83± 0.05, sensitivity 0.84±0.06). For multiclass classification, the AUROCs were 0.80 ± 0.06 (LVH), 0.78±0.05 (microvoltage) and 0.76±0.05 (controls). Conclusion This is the first study to detect ECG abnormalities in amplitude and intraventricular conduction, with a four precordial electrodes set-up. DTs based on miniECG features offer an interpretable detection method with a performance that was comparable to other less interpretable models. Before clinical implementation, further research is necessary to optimize DT-structures and analyze abnormalities beyond the current study. Author Summary Electrocardiograms (ECGs) are vital for detecting abnormal electrical heart signals, but traditional 12-lead ECGs are often limited to in-hospital settings due to complexity. Our study introduces the miniECG, a smartphone-size device with four electrodes to be placed on the chest, that records eight leads. We evaluated its ability to detect amplitude and conduction cardiac abnormalities using interpretable machine learning models. In a hospital-based sample of over 1,700 patients, we trained decision trees (DTs) on standard ECG features to classify abnormalities. The models demonstrated accurate diagnostic potential, particularly for conduction abnormalities, while maintaining transparency and clinical interpretability. Further optimization is needed, but this tool could enable broader ECG acquisition and easier detection of cardiac abnormalities.